Bert Andersson

Bert Andersson's AcademicInfluence.com Rankings

Bert Andersson

Chemistry

#5607

World Rank

#6810

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Bert Andersson's Degrees

PhD Chemistry Stanford University
Masters Chemistry Stanford University
Bachelors Chemistry Stanford University

Why Is Bert Andersson Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Bert Andersson's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in-Congestive Heart Failure (MERIT-HF) (1999) (4830)
Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. (2007) (2426)
2015 ESC Guidelines for the diagnosis and management of pericardial diseases (2015) (1246)
Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis (2014) (399)
Beta-blockers for heart failure with reduced, mid-range, and preserved ejection fraction: an individual patient-level analysis of double-blind randomized trials (2018) (372)
Mapping of a functional autoimmune epitope on the beta 1-adrenergic receptor in patients with idiopathic dilated cardiomyopathy. (1990) (254)
Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. (2013) (252)
The Myocardium-protective Gly-49 Variant of the β1-Adrenergic Receptor Exhibits Constitutive Activity and Increased Desensitization and Down-regulation* (2002) (227)
Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler‐echocardiographic study (SWEDIC) (2004) (224)
A novel polymorphism in the gene coding for the beta(1)-adrenergic receptor associated with survival in patients with heart failure. (2000) (220)
Effects of spinal cord stimulation in angina pectoris induced by pacing and possible mechanisms of action. (1993) (210)
Proceedings from the European clinical consensus conference for renal denervation: considerations on future clinical trial design. (2015) (175)
Heart Rate and Rhythm and the Benefit of Beta-Blockers in Patients With Heart Failure. (2017) (174)
Target Temperature Management after out-of-hospital cardiac arrest--a randomized, parallel-group, assessor-blinded clinical trial--rationale and design. (2012) (166)
The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathic heart failure. (1996) (161)
Blood pressure changes after renal denervation at 10 European expert centers (2013) (159)
Growth factors and interleukin-6 across the lung circulation in pulmonary hypertension (2009) (149)
Exploring symptoms in chronic heart failure (2005) (133)
Scandinavian glutamine trial: a pragmatic multi‐centre randomised clinical trial of intensive care unit patients (2011) (128)
Spectrum and outcome of congestive heart failure in a hospitalized population. (1993) (128)
Hydrotherapy—a new approach to improve function in the older patient with chronic heart failure (2003) (125)
Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal in Heart Transplant Recipients: A Randomized Trial (2014) (116)
Exercise hemodynamics and myocardial metabolism during long-term beta-adrenergic blockade in severe heart failure. (1991) (110)
Long‐term cardiovascular effects of growth hormone treatment in GH‐deficient adults Preliminary data in a small group of patients (1996) (102)
Ser49Gly of β1‐adrenergic receptor is associated with effective β‐blocker dose in dilated cardiomyopathy (2005) (99)
Myocardial Turnover of Endogenous Opioids and Calcitonin-Gene-Related Peptide in the Human Heart and the Effects of Spinal Cord Stimulation on Pacing-Induced Angina Pectoris (1998) (96)
Effect of age and sex on efficacy and tolerability of β blockers in patients with heart failure with reduced ejection fraction: individual patient data meta-analysis (2016) (95)
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Three‐Year Results From the Randomized SCHEDULE Study (2016) (94)
Changes in early and late diastolic filling patterns induced by long-term adrenergic beta-blockade in patients with idiopathic dilated cardiomyopathy. (1996) (87)
Intravenous levosimendan vs. dobutamine in acute decompensated heart failure patients on beta-blockers (2010) (86)
Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. (1994) (79)
Effects of pacing-induced myocardial stress and spinal cord stimulation on whole body and cardiac norepinephrine spillover. (1997) (76)
Assessment of pulmonary vascular resistance by Doppler echocardiography in patients with pulmonary arterial hypertension. (2007) (75)
Immersion in warm water induces improvement in cardiac function in patients with chronic heart failure (2006) (75)
Increased exercise ejection fraction and reversed remodeling after long‐term treatment with metoprolol in congestive heart failure: a randomized, stratified, double‐blind, placebo‐controlled trial in mild to moderate heart failure due to ischemic or idiopathic dilated cardiomyopathy (2003) (71)
Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy. (2005) (65)
The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure. A study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. (1993) (61)
Ventricular long-axis function is of major importance for long-term survival in patients with heart failure (2007) (58)
Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis. (2015) (57)
Rationale, design, and organization of the metoprolol CR/XL randomized intervention trial in heart failure (MERIT-HF) (1997) (54)
Angiotensin‐II type 1 receptor gene polymorphism and long‐term survival in patients with idiopathic congestive heart failure (1999) (54)
Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry (2019) (53)
High and low pulmonary vascular resistance in heart transplant candidates. A 5-year follow-up after heart transplantation shows continuous reduction in resistance and no difference in complication rate. (1999) (53)
The Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Recipients: One‐Year Results of a Scandinavian Randomized Trial (2015) (51)
Differential Effects of Levosimendan and Dobutamine on Glomerular Filtration Rate in Patients With Heart Failure and Renal Impairment:A Randomized Double‐Blind Controlled Trial (2018) (50)
Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta‐analysis (2015) (49)
Reliability of Clinical Muscular Endurance Tests in Patients with Chronic Heart Failure (2006) (47)
Cardiorespiratory effects of warm water immersion in elderly patients with chronic heart failure (2005) (46)
Self‐assessed symptoms in chronic heart failure — Important information for clinical management (2007) (45)
3-year follow-up of patients randomised in the metoprolol in dilated cardiomyopathy trial (1998) (41)
Pharmacokinetic Considerations of Formulation: Extended-Release Metoprolol Succinate in the Treatment of Heart Failure (2003) (39)
Cardiac neuropeptide Y and noradrenaline balance in patients with congestive heart failure. (1994) (39)
Risk of Idiopathic Dilated Cardiomyopathy in 29 000 Patients With Celiac Disease (2012) (37)
Benefit of warm water immersion on biventricular function in patients with chronic heart failure (2009) (33)
Different responses to dobutamine in the presence of carvedilol or metoprolol in patients with chronic heart failure (2003) (32)
Optimizing the Management of Heart Failure With Preserved Ejection Fraction in the Elderly by Targeting Comorbidities (OPTIMIZE-HFPEF). (2016) (32)
Potential risk of beta-blockade withdrawal in congestive heart failure due to abrupt autonomic changes. (1999) (31)
Impact of Renal Impairment on Beta-Blocker Efficacy in Patients With Heart Failure. (2019) (31)
Idiopathic dilated cardiomyopathy among Swedish patients with congestive heart failure. (1995) (30)
Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy. (2000) (30)
Antibodies against the beta1-adrenergic receptor induce progressive development of cardiomyopathy. (2007) (29)
CABG Improves Outcomes in Patients With Ischemic Cardiomyopathy: 10-Year Follow-Up of the STICH Trial. (2019) (29)
An echocardiographic evaluation of patients with idiopathic heart failure. (1995) (29)
N-terminal proatrial natriuretic peptide and prognosis in patients with heart failure and preserved systolic function. (2000) (28)
Heart rate dependency of cardiac performance in heart failure patients treated with metoprolol. (1999) (27)
Gender and age related differences in left ventricular function and geometry with focus on the long axis. (2006) (27)
Dose-related effects of metoprolol on heart rate and pharmacokinetics in heart failure. (2001) (26)
Induction of Cardiomyopathy in Severe Combined Immunodeficiency Mice by Transfer of Lymphocytes from Patients with Idiopathic Dilated Cardiomyopathy (2000) (25)
[Classification of the cardiomyopathies]. (2008) (25)
Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation (2018) (24)
Coronary flow reserve in patients with resistant hypertension (2017) (23)
Longitudinal myocardial contraction improves early during titration with metoprolol CR/XL in patients with heart failure (2002) (23)
Parvovirus B19 in Endomyocardial Biopsy of Patients With Idiopathic Dilated Cardiomyopathy: Foe or Bystander? (2019) (21)
Influence of central inhibition of sympathetic nervous activity on myocardial metabolism in chronic heart failure: acute effects of the imidazoline I1-receptor agonist moxonidine. (2006) (20)
Adherence to optimal heart rate control in heart failure with reduced ejection fraction: insight from a survey of heart rate in heart failure in Sweden (HR-HF study) (2017) (19)
Early changes in longitudinal performance predict future improvement in global left ventricular function during long term β adrenergic blockade (2000) (18)
Recovery from left ventricular asynergy in ischemic cardiomyopathy following long-term beta blockade treatment. (1994) (18)
Pulmonary hemodynamics as predictors of mortality in patients awaiting lung transplantation (2008) (17)
Massive parallel sequencing questions the pathogenic role of missense variants in dilated cardiomyopathy. (2017) (16)
Graft coronary artery disease is strongly related to the aetiology of heart failure and cellular rejections. (1999) (16)
Prognosis of alternative therapies in patients with heart failure not accepted for heart transplantation. (1995) (15)
TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure. (2008) (15)
Lower levels of the host protective IL-10 in DCM—a feature of autoimmune pathogenesis? (2008) (15)
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study (2020) (14)
Temporal improvement in heart failure survival related to the use of a nurse-directed clinic and recommended pharmacological treatment. (2005) (14)
The association between blood pressure and long-term outcomes of patients with ischaemic cardiomyopathy with and without surgical revascularization: an analysis of the STICH trial (2018) (12)
The effects of baroreflex activation therapy on blood pressure and sympathetic function in patients with refractory hypertension: the rationale and design of the Nordic BAT study* (2017) (12)
Right ventricular ejection fraction during exercise as a predictor of mortality in patients awaiting lung transplantation: a cohort study (2013) (12)
Continuous improvement in outcome after heart transplantation - Long-term follow-up after three decades of experience. (2017) (12)
Factors influencing long-term heart failure mortality in patients with obstructive hypertrophic cardiomyopathy in Western Sweden: probable dose-related protection from beta-blocker therapy (2019) (11)
Hypertension is associated with increased mortality in patients with ischaemic heart disease after revascularization with percutaneous coronary intervention – a report from SCAAR* (2017) (10)
291 Gender and age‐related differences in left ventricular function and geometry with focus on the long axis (2005) (9)
The validation of a new quality of life questionnaire for patients with congestive heart failure–an extension of the Cardiac Health Profile (2007) (9)
Impaired activation of IFN-gamma+CD4+ T cells in peripheral blood of patients with dilated cardiomyopathy. (2010) (9)
Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension (2014) (8)
Arterial embolism and atrial arrhythmias. (1989) (7)
Short atrioventricular delay pacing therapy in young and old patients with hypertrophic obstructive cardiomyopathy: good long-term results and a low need for reinterventions (2017) (7)
Pronounced improvement in systolic and diastolic ventricular long axis function after treatment with metoprolol (2007) (7)
Cardiac arrest in Wilson's disease after curative liver transplantation: a life‐threatening complication of myocardial copper excess? (2019) (7)
Safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 12-month results from the ACHIEVE study. (2019) (7)
TCT-423 The Paradise Renal Denervation System: Initial Clinical Results from the ACHIEVE Study (2014) (6)
Influence of age, hypertension, and diabetes on cardiac reserve in a rat model. (2006) (6)
Early post-transplant elevated pulmonary artery pressure predicts adverse outcome in cardiac recipients (2019) (5)
Cardiac reserve in the transplanted heart: effect of a graft polymorphism in the beta1-adrenoceptor. (2007) (5)
[Better and better results of heart transplantation. Analysis of 25 years of collected experiences]. (2009) (5)
Metoprolol reduces sympathetic nerve hyperactivity in patients with heart failure. (2001) (5)
Effect of Calcineurin Inhibitor–Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation (2017) (5)
Three Year Follow Up of the Randomized SCHEDULE Trial With Everolimus Initiation and Early Withdrawal of Calcineurin Inhibitor Therapy in De Novo Heart Transplant Recipients - A Multicenter, Randomized Scandinavian Trial (2015) (4)
Mild acute cellular rejection and development of cardiac allograft vasculopathy assessed by intravascular ultrasound and coronary angiography in heart transplant recipients—a SCHEDULE trial substudy (2020) (4)
A Polymorphism at Position +874 in The IFN-γ Gene is Associated with Susceptibility for Dilated Cardiomyopathy (2010) (4)
Carvedilol improves diastolic function in patients with diastolic heart failure. (2001) (4)
Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients (2014) (4)
Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials (2015) (4)
NATRIURETIC PEPTIDES AND CONTRACTILE RESERVE IN DILATED CARDIOMYOPATHY. AUTHOR'S REPLY (1998) (3)
Monday, 27 August 2012 (2012) (3)
Endothelin-1 across the lung circulation in patients with pulmonary arterial hypertension and influence of epoprostenol infusion. (2009) (3)
Morbidity and resource usage after myectomy- or pacing-treatment in hypertrophic obstructive cardiomyopathy: A case-control study. (2020) (3)
Heart rate, heart rhythm and prognostic benefits of beta-blockers in heart failure: individual patient-data meta-analysis (2017) (3)
The DD genotype of the ACE-gene is associated with increased mortality in idiopathic heart failure (1996) (3)
Everolimus and Cyclosporine Equally Improve QoL in De Novo Heart Transplanted Patients: The Results of a Randomized Controlled Trial (SCHEDULE Trial) (2014) (2)
320: Thoracic organ transplantations in the Nordic countries 1983-2005, Nordic Thoracic Transplantation Study Group. 1st official registry report–2006 (2007) (2)
[Nurse-managed clinic provides a good foundation for heart failure patients]. (2002) (2)
Maintained Cardiac Reserve in Heart Transplant Patients During Early Calcineurin Inhibitor Avoidance: A Substudy of a Randomised Controlled Trial (SCHEDULE Trial) (2013) (2)
Scandinavian Heart Transplant Everolimus De Novo Study with Early Calcineurin Inhibitor Avoidance (SCHEDULE) (2013) (2)
A CNI-Free, Everolimus Based Regimen in De-Novo Heart Transplant Recipients Increases Albuminuria But Improves Glomerular Filtration Rate Compared With Conventional Immunosuppression (2014) (2)
The function of left ventricular basal segments is most important for long-term recovery. (2007) (2)
Transluminal Imaging of Renal Nerves using Optical Coherence Tomography (2014) (1)
CRT-200.22 Safety And Efficacy Of Renal Sympathetic Denervation Using Circumferential Ultrasound: 12-month Results of the ACHIEVE Study (2018) (1)
Early Calcineurin Inhibitors Elimination Improves Renal Function in De Novo Heart Transplant Recipients: The Results of a Randomized Controlled Trial (SCHEDULE Trial).: Abstract# 1324 (2014) (1)
Invasive haemodynamics in de novo everolimus vs. calcineurin inhibitor heart transplant recipients (2020) (1)
The therapeutic potential of immune therapy in idiopathic dilated cardiomyopathy. (2005) (1)
Long-term outcome in heart failure patients evaluated for heart transplantation but considered too well. (2006) (1)
Exercise Capacity in De-Novo Heart Transplant Recipents With Everolimus Vs Conventional CNI Based Immunosuppresion. The Results of a Randomized Trial (SCHEDULE) (2014) (1)
Early calcineurin inhibitors avoidance improves renal function in de novo heart transplant recipients: The results of a randomized controlled trial (SCHEDULE trial) (2013) (1)
P1023 Has the natural course of heart failure finally improved (2003) (1)
[PP.13.09] THE EFFECTS OF BAROREFLEX ACTIVATION THERAPY ON BLOOD PRESSURE AND SYMPATHETIC FUNCTION IN PATIENTS WITH REFRACTORY HYPERTENSION – THE RATIONALE AND DESIGN OF THE NORDIC BAT STUDY (2016) (1)
5698Parvovirus B19 in endomyocardial biopsy of patients with idiopathic dilated cardiomyopathy: foe or bystander? (2017) (1)
Unaltered neurocardiovascular reactions to mental stress after renal sympathetic denervation (2020) (1)
Differential Effects of Levosimendan and Dobutamine on GFR in Patients With Heart Failure and Renal Impairment. A Randomized Double-blind Controlled Trial (2018) (0)
Plasma Adiponectin in Patients Pulmonary Arterial Hypertension (2013) (0)
Influence of preload on apex cardiogram and mitral Doppler in the assessment of diastolic left ventricular (LV) function in dilated cardiomyopathy (2006) (0)
40 Preoperative hemodynamic evaluation is predictive of long-term outcome after lung transplantation (2004) (0)
P5273Adherence to optimal heart rate control in heart failure with reduced ejection fraction: Insight from a survey of heart rate in heart failure in Sweden (HR-HF study) - a prospective multicenter study (2017) (0)
530: Endothelin-1 (ET-1) Serum Levels: Relation to Hemodynamics and Clinical Variables in Patients with Pulmonary Vascular Disease (2009) (0)
Mild Acute Cellular Rejection is Not Associated with Development of Cardiac Allograft Vasculopathy Assessed by Intravascular Ultrasound and Coronary Angiography in Heart Transplant Recipients - A Substudy of the SCHEDULE Trial (2019) (0)
439: Does Diastolic Dysfunction Contribute to Pulmonary Hypertension in Patients with Advanced COPD Awaiting Lung Transplantation? (2010) (0)
Renal sympathetic denervation in patients with therapy resistant hypertension (2013) (0)
709: Influence of Intravenous Epoprostenol on the Transpulmonary Gradient of Vascular Endothelial Growth Factor (VEGF) in Patients with Pulmonary Arterial Hypertension (2009) (0)
OPTIMAL MEDICAL THERAPY USE AND LONG-TERM OUTCOMES IN CABG-ELIGIBLE HEART FAILURE PATIENTS: INSIGHTS FROM THE STICH TRIAL (2019) (0)
1224 A new doppler echocardiographic approach for hemodynamic assessment of patients with pulmonary arterial hypertension (2006) (0)
Natriuretic peptides and contractile reserve in dilated cardiomyopathy (1998) (0)
PS 14-65 THE EFFECTS OF BAROREFLEX ACTIVATION THERAPY ON BLOOD PRESSURE AND SYMPATHETIC FUNCTION IN PATIENTS WITH REFRACTORY HYPERTENSION – THE RATIONALE AND DESIGN OF THE NORDIC BAT STUDY (2016) (0)
[Peripartumcardiomyopathy an often missed diagnosis]. (2013) (0)
49 Different chronotropic and inotropic reactions to low dose dobutamin stress in the transplanted heart (2004) (0)
What do tachycardiomyopathy belong to?: reply (2008) (0)
652 Self assessed symptoms are predictive of long‐term survival in chronic heart failure (2005) (0)
Effect of age and sex on efficacy and tolerability of beta blockers in patients with heart failure with reduced ejection fraction (2016) (0)
Long-term Effect on Albuminuria and Glomerular Filtration Rate of a Calcineurin Inhibitor-Free Everolimus Based Immunosuppressive Regimen after Heart Transplantation (2016) (0)
39: Cardiac reserve in the transplanted heart depends on a graft polymorphism in the beta-1-adrenergic receptor (2007) (0)
429 Decreased right ventricular long axis function is a significant risk factor for long-term mortality in patients with idiopathic heart failure, with and without atrial fibrillation (2005) (0)
Specific Therapy Modulate Circulating Levels of Adiponectin in Patients with Pulmonary Arterial Hypertension (2013) (0)
[Catheter-based renal denervation: a new method for resistant hypertension. Initial experiences of the procedure shows significant decrease in blood pressure]. (2013) (0)
Cardiorespiratory effects of submaximal exercise in warm water in elderly patients with congestive heart failure (2000) (0)
97: Novel Doppler echocardiographic approach for assessment of pulmonary vascular resistance in patients with pulmonary arterial hypertension (2006) (0)
The Prognostic Impact of One-Year Hemodynamics on Long-Term Survival After Heart Transplantation (2016) (0)
Prognostic value of exercise radionuclide angio graphy in patients with dilated cardiomyopathy (1995) (0)
236 Regional contractile reserve predicts the effects of beta‐blockade treatment in cardiomyopathy patients (2005) (0)
441: Predictors of Right Ventricular Function in Lung Transplant Candidates (2010) (0)
528: Three different approaches for non-invasive estimation of pulmonary artery mean pressure in patients with pulmonary arterial hypertension (2007) (0)
The Effect of Everolimus Initiation and Early Calcineurin Inhibitor Withdrawal on Allograft Vasculopathy in De-Novo Heart Transplant: Recipients: Results of the SCHEDULE Trial After 36 Months (2015) (0)
Effect of renal denervation on coronary flow reserve in patients with resistant hypertension (2019) (0)
834 Circulating Levels of the Stromal Derived Factor 1 α in Patients with Pulmonary Arterial Hypertension (2012) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Bert Andersson?

Bert Andersson is affiliated with the following schools:

University of California, Berkeley
Stanford University
University of Gothenburg